合成路线1
该中间体在本合成路线中的序号:
(II) The condensation of ethyl 4-(bromomethyl)cinnamate (I) with imidazole (II) by means of NaH in DMF give ethyl 4-(1-imidazolylmethyl)cinnamate (III), wich is hydrolyzed with NaOH in methanol - water, and acidified with HCl.
【1】
Bergstrom, S.; Carlson, L.A.; Weeks, J.R.; The protaglandins: A family of biologically active lipids. J Med Chem 1981, 24, 10, 409-412.
|
【2】
Iizuka, K.; Akahane, K.; Kamijo, Y.; Momose, D.; Matsumoto, A.; Yukiyoshi, O. (Kissei Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.); Imidazole derivative. DE 2923815; GB 2025946; US 4226878 .
|
【3】
Blancafort, P.; Serradell, M.N.; Pento, J.T.; Castaner, J.; OKY-046. Drugs Fut 1983, 8, 4, 328.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30685 |
ethyl (E)-3-[4-(bromomethyl)phenyl]-2-propenoate; ethyl 4-(bromomethyl)cinnamate
|
|
C12H13BrO2 |
详情 |
详情
|
(II) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(III) |
30686 |
ethyl (E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoate; 4-(1-Imidazolylmethyl)cinnamate
|
|
C15H16N2O2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) By reaction of 2-naphthyl bromomethyl ketone (I) with imidazole (II) in DMF, followed by a treatment with HCl in ether.
【1】
Walker, K.A.M.; GB 1540023 .
|
【2】
Hirschfeld, D.R.; Walker, K.A.M.; Wallach, M.B.; 1-(Naphthylalyl)-1H-imidazole derivatives, a new class of anticonvulsant agents. J Med Chem 1981, 24, 1, 67.
|
【3】
Walker, K.A.M. (Syntex (USA), Inc.); 1-(Naphthylethyl)imidazole derivs., their preparation, and pharmaceutical compsns. containing them. EP 0001926 .
|
【4】
Walker, K.A.M. (Syntex (USA), Inc.); Imidazole derivs., their preparation and their use in pharmaceutical compsns.. EP 0013786 .
|
【5】
Serradell, M.N.; Blancafort, P.; Castaner, J.; Nafimidone hydrochloride. Drugs Fut 1983, 8, 8, 689.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36166 |
2-bromo-1-(2-naphthyl)-1-ethanone
|
613-54-7 |
C12H9BrO |
详情 | 详情
|
(II) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(III) The reduction of 2,4-dichlorophenacyl chloride with NaBH4 gives 1-(2,4-dichlorophenyl)-2-chloroethanol (II), which is condensed with imidazole (III) to yield 1-(2,4-dichlorophenyl)-2-(N-imidazolyl)ethanol (IV). Finally, this compound is condensed with 4-(phenylthio)benzyl chloride (V) [prepared by chloromethylation of diphenyl sulfide (VI) with formaldehyde and HCl] using NaH as condensing agent.
【1】
Cova, A.; Tajana, A.; Nardi, D.; Cappelleti, R.; Sibilia, C.; Physico-chemical, structural and analytical studies on fenticonazole, a new drug with antimycotic properties. Arzneim-Forsch Drug Res 1981, 31, 12, 2127.
|
【2】
Nardi, D.; Massarani, E.; Tajana, A.; Veronese, M. (Recordati Industria Chimica e Farmaceutica SpA); Substituted dibenzyl ethers and parmaceutical compositions containing said ethers for the treatment of infections. DE 2917244; FR 2426047; GB 2025395; US 4221803 . |
【3】
Blancafort, P.; Castaner, J.; Serradell, M.N.; Fenticonazole Nitrate. Drugs Fut 1983, 8, 9, 767.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31092 |
2,2',4'-trichloroacetophenone; 2-chloro-1-(2,4-dichlorophenyl)-1-ethanone
|
4252-78-2 |
C8H5Cl3O |
详情 | 详情
|
(II) |
31093 |
2-chloro-1-(2,4-dichlorophenyl)-1-ethanol
|
13692-14-3 |
C8H7Cl3O |
详情 | 详情
|
(III) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(IV) |
14550 |
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-1-ethanol; alpha-(2,4-Dichlorophenyl)-1H-imidazole-1-ethanol; 1-(2',4'-Dichlorophenyl)-2-(1-imidazolyl)ethanol
|
24155-42-8 |
C11H10Cl2N2O |
详情 | 详情
|
(V) |
31094 |
1-(chloromethyl)-4-(phenylsulfanyl)benzene; 4-(chloromethyl)phenyl phenyl sulfide
|
|
C13H11ClS |
详情 |
详情
|
(VI) |
23188 |
1-(phenylsulfanyl)benzene; diphenyl sulfide
|
139-66-2 |
C12H10S |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(B) The chlorohydrin (II) is obtained by the reaction of p-chlorobenzylmagnesium chloride (I) with epichlorohydrin (A) in ether. This is then converted to the crystalline alcohol (III) by reaction with sodium imidazole (B) in DMF. On treatment with thionyl chloride is converted to the corresponding chloro compound (IV). When (IV) is reacted with 2,6-dichloro thiophenol (C) in the presence of anhydrous potassium carbonate in acetone, the free base of butoconazole is formed. Neutralization of the free base (V) with nitric acid gives butoconazole.
【1】
Walker, K.A.M.; et al.; 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenylthio)n-butil]-1H-imidazole nitrate, a new patent antifungal agent. J Med Chem 1978, 21, 8, 840.
|
【2】
Arya, V.P.; Butoconazole nitrate. Drugs Fut 1979, 4, 2, 89.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(B) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(I) |
33290 |
Bromo(4-chlorobenzyl)magnesium; p-Chlorobenzylmagnesium chloride
|
|
C7H6BrClMg |
详情 |
详情
|
(II) |
33291 |
1-chloro-4-(4-chlorophenyl)-2-butanol
|
|
C10H12Cl2O |
详情 |
详情
|
(III) |
16486 |
4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanol
|
|
C13H15ClN2O |
详情 |
详情
|
(IV) |
33292 |
1-[2-chloro-4-(4-chlorophenyl)butyl]-1H-imidazole
|
|
C13H14Cl2N2 |
详情 |
详情
|
(V) |
33294 |
1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl]-1H-imidazole; 3-(4-chlorophenyl)-1-(1H-imidazol-1-ylmethyl)propyl 2,6-dichlorophenyl sulfide
|
|
C19H17Cl3N2S |
详情 |
详情
|
(C) |
33293 |
2,6-Dichloro thiophenol; 2,6-Dichlorobenzenethiol; 2,6-Dichlorophenylhydrosulfide
|
24966-39-0 |
C6H4Cl2S |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(III) The Oxidation of 1-octyn-3-ol (I) with chromium trioxide gives the 3-oxooctyne (II), which by reaction with imidazole (III) yields (E)-1-(3-oxoocten-1-yl)imidazole (IV). Reduction of this compound with sodium borohydride gives (E)-1,3-hydroxyocten-1-yl)imidazole (V) . Finally, the latter is etherified with benzyl chloride (VI).
【1】
Pailer, N.; Gutwiller, H.; Mh Chem 1977, 108, Suppl. 1, 653.
|
【2】
Bonne, C.; Coquelet, C.; Sincholle, D. (Chauvin Laboratories SA); Therapeutic compsn. based on imidazoles, especially for the treatment of thromboses; imidazoles and process for their preparation. EP 0033432 .
|
【3】
Blancafort, P.; Serradell, M.N.; Castaner, J.; CBS-645. Drugs Fut 1983, 8, 10, 843.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36230 |
1-Octyn-3-ol
|
818-72-4 |
C8H14O |
详情 | 详情
|
(II) |
36231 |
1-octyn-3-one
|
|
C8H12O |
详情 |
详情
|
(III) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(IV) |
36232 |
(E)-1-(1H-imidazol-1-yl)-1-octen-3-one
|
|
C11H16N2O |
详情 |
详情
|
(V) |
36233 |
(E)-1-(1H-imidazol-1-yl)-1-octen-3-ol
|
|
C11H18N2O |
详情 |
详情
|
(VI) |
19171 |
1-(Chloromethyl)benzene; Benzyl chloride
|
100-44-7 |
C7H7Cl |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(A) The condensation of 2-methyl-3-(1H-imidazol-1-ylmethyl)indole (III) with acrylonitrile (IV) by means of benzyltrimethylammonium hydroxide (B) in dioxane gives 1-(2-cyanoethyl)-2-methyl-3-(1H-imidazol-1-ylmethyl)indole (V), which is then hydrolyzed with KOH in water. The reaction of compound (III) with methyl acrylate (VI) in the same conditions as before gives 1-(2-methoxy-carbonylethyl)-2-methyl-3-(1H-imidazol-1-ylmethyl)indole (VII), which is also hydrolyzed. Compound (III) can be obtained from 2-methylindole (I).
【1】
Cross, P.E.; Dickinson, R.P.; Randall, M.J.; Parry, M.J.; K-38485, a novel, selective thromboxane synthetase inhibitor with prolonged activity in vivo. N Am Med Chem Symp 1982, 68.
|
【2】
Cross, P.E.; Dickinson, R.P. (Pfizer Inc.); Inhibition of thromboxane synthetase by 3-(1-imidazolylalkyl)indoles. NL 8001351 .
|
【3】
Serradell, M.N.; Castaner, J.; Blancafort, P.; Grau, M.; UK-38485. Drugs Fut 1983, 8, 11, 947.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(B) |
36194 |
N,N,N-trimethyl(phenyl)methanaminium
|
4525-46-6 |
C10H16N |
详情 | 详情
|
(I) |
28747 |
2-methyl-1H-indole
|
95-20-5 |
C9H9N |
详情 | 详情
|
(II) |
36192 |
N,N-dimethyl-N-[(2-methyl-1H-indol-3-yl)methyl]amine; N,N-dimethyl(2-methyl-1H-indol-3-yl)methanamine
|
|
C12H16N2 |
详情 |
详情
|
(III) |
36193 |
3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole
|
|
C13H13N3 |
详情 |
详情
|
(IV) |
10847 |
Acrylonitrile
|
107-13-1 |
C3H3N |
详情 | 详情
|
(V) |
36195 |
3-[3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indol-1-yl]propanenitrile
|
|
C16H16N4 |
详情 |
详情
|
(VI) |
14156 |
methyl acrylate
|
96-33-3 |
C4H6O2 |
详情 | 详情
|
(VII) |
36196 |
methyl 3-[3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indol-1-yl]propanoate
|
|
C17H19N3O2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(V) A new synthesis of dazoxiben has been described:
The condensation of methyl 4-hydroxybenzoate (I) with 1,2-dibromoethane (II) by means of NaOH gives methyl 4-(2-bromoethoxy)benzoate (III), which is hydrolyzed with H2SO4 to the corresponding free acid (IV). Finally, this compound is condensed with imidazole (V) in refluxing butanol.
【1】
Palei, R.M.; Kochergin, P.M.; Balandina, L.V.; Govorukhina, E.I.; Persanova, L.V.; Frolova, M.A.; Kravchenko, A.N.; Kharitonova, A.E.; A simplified synthesis of dazoxibene. Khim Farm Zh 1995, 29, 2, 56.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10251 |
methyl 4-hydroxybenzoate; Methyl p-hydroxybenzoate
|
99-76-3 |
C8H8O3 |
详情 | 详情
|
(II) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(III) |
10253 |
methyl 4-(2-bromoethoxy)benzoate
|
56850-91-0 |
C10H11BrO3 |
详情 | 详情
|
(IV) |
10254 |
4-(2-bromoethoxy)benzoic acid
|
51616-09-2 |
C9H9BrO3 |
详情 | 详情
|
(V) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) This compound can be obtained in several different ways:
1) The condensation of imidazole (I) with 4-(2-chloroethoxy)benzamide (II) by means of NaH in DMF gives 1-[2-(4-carbamoylphenoxy)ethyl]imidazole (III), which is hydrolyzed by refluxing with 5N aqueous HCl.
2) Esters of 4-(2-chloroethoxy)benzoic acid (IV) can also be used instead of (II) in the first step of the synthesis.
3) This compound can also be obtained by direct condensation of imidazole (I) with 4-(2-chloroethoxy)benzoic acid (IV) by means of NaH in THF.
【1】
DE 2950019 .
|
【2】
Sneddon, J.; Castaner, J.; UK-37,248-01. Drugs Fut 1981, 6, 11, 693.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
39008 |
4-(2-chloroethoxy)benzamide
|
|
C9H10ClNO2 |
详情 |
详情
|
(III) |
39009 |
4-[2-(1H-imidazol-1-yl)ethoxy]benzamide
|
|
C12H13N3O2 |
详情 |
详情
|
(IV) |
39010 |
4-(2-chloroethoxy)benzoic acid
|
|
C9H9ClO3 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) The condensation of imidazole (I) with 4-(phenethyl)phenacyl chloride (II) in DMF gives 1-[4-(phenethyl)phenacyl]imidazole (III), which is then reduced with NaBH4 in refluxing methanol.
【1】
Pennini, R.; Tajana, A.; Magistretti, M.J.; Portioli, F.; Nardi, D.; Leonardi, A.; Subissi, A.; Synthesis and anticonvulsant avtivity of N-(benzoylalkyl)imidazoles and N-(omega-phenyl-omega-hydroxyalkyl)imidazoles. J Med Chem 1981, 24, 6, 727-731.
|
【2】
Nardi, D.; Tajana, A.; Magistretti, M.J. (Recordati Industria Chimica e Farmaceutica SpA); Imidazole derivs.. DE 2929777 .
|
【3】
Castaner, J.; Serradell, M.N.; Blancafort, P.; de Angelis, L.; Denzimol. Drugs Fut 1983, 8, 11, 915.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
36215 |
2-chloro-1-(4-phenethylphenyl)-1-ethanone
|
|
C16H15ClO |
详情 |
详情
|
(III) |
36216 |
2-(1H-imidazol-1-yl)-1-(4-phenethylphenyl)-1-ethanone
|
|
C19H18N2O |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(III) The diazotation of 2-amino-4-chloroanisole (I) with NaNO2 and HCl in water gives the corresponding diazonium salt (II), which is then condensed with imidazole (III) by means of NaOH and sodium acetate in water.
【1】
Niimura, I.; Maeda, S.; Okazaki, H. (Mochida Pharmaceutical Co., Ltd.); Azo cpds.. DE 3028928 .
|
【2】
Mochida, E.; Suzuki, Y.; Onishi, H.; Kosuzume, H. (Mochida Pharmaceutical Co., Ltd.); Compsns. containing azo cpds. and use thereof for therapeutic treatment. GB 2057874 .
|
【3】
Blancafort, P.; Serradell, M.N.; Grau, M.; Castaner, J.; M-6434. Drugs Fut 1982, 7, 12, 887.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37092 |
5-chloro-2-methoxyphenylamine; 5-chloro-2-methoxyaniline
|
95-03-4 |
C7H8ClNO |
详情 | 详情
|
(II) |
37093 |
|
|
C7H7Cl2NO |
详情 |
详情
|
(III) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(III) The reduction of 4-phenylbenzophenone (I) with NaBH4 in ethanol gives 4-phenylbenzhydrol (II), which is then condensed with imidazole (III) by means of SOCl2 in acetonitrile.
【1】
Regel, E.; Draber, W.; Buechel, K.H.; Plempel, M. (Bayer AG); alpha-(4-Biphenylyl)-benzylazolium salts and their use for combating microorganisms. BE 0859041; DE 2643563; FR 2365559; GB 1535148; JP 53044568; NL 7710489; US 4243670 .
|
【2】
Regel, E.; Draber, W.; Buechel, K.H.; Plempel, M. (Bayer AG); Substituted azol-1-ylmethanes. BE 0836924; CA 1059134; CH 619454; DD 124729; DE 2461406; FR 2295747; GB 1469617; JP 51091260; NL 7514940; US 4118487 .
|
【3】
Regel, E.; Draber, W.; Buechel, K.H.; Plempel, M. (Bayer AG); Combating crop damaging fungi with alpha-(4-biphenylyl)-benzyl-azolium salts. DE 2714290; JP 53121941; US 4251540 .
|
【4】
Serradell, M.N.; Blancafort, P.; Castaner, J.; Bifonazole. Drugs Fut 1982, 7, 2, 87.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31709 |
[1,1'-biphenyl]-4-yl(phenyl)methanone
|
2128-93-0 |
C19H14O |
详情 | 详情
|
(II) |
31710 |
[1,1'-biphenyl]-4-yl(phenyl)methanol
|
|
C19H16O |
详情 |
详情
|
(III) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) The condensation of ethyl 4-(bromomethyl) cinnamate (I) with imidazole (II) by means of NaH in DMF gives ethyl 4-(1-imidazolylmethyl) cinnamate (III), which is hydrolyzed with NaOH in methanol / water, and acidified with HCl.
【1】
Bergstrom, S.; Carlson, L.A.; Weeks, J.R.; The protaglandins: A family of biologically active lipids. J Med Chem 1981, 24, 10, 409-412.
|
【2】
Iizuka, K.; Akahane, K.; Kamijo, Y.; Momose, D.; Matsumoto, A.; Yukiyoshi, O. (Kissei Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.); Imidazole derivative. DE 2923815; GB 2025946; US 4226878 .
|
【3】
Blancafort, P.; Serradell, M.N.; Pento, J.T.; Castaner, J.; OKY-046. Drugs Fut 1983, 8, 4, 328.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30685 |
ethyl (E)-3-[4-(bromomethyl)phenyl]-2-propenoate; ethyl 4-(bromomethyl)cinnamate
|
|
C12H13BrO2 |
详情 |
详情
|
(II) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(III) |
30686 |
ethyl (E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoate; 4-(1-Imidazolylmethyl)cinnamate
|
|
C15H16N2O2 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(A) The reaction of 2,4-dichlorophenacyl chloride (I) with imidazole (A) gives the ketone (II), which is reduced with sodium borohydride to yield the alcohol (III). Conversion of the alcohol (III) to the chloro derivative (IV) with thionylchloride followed by reaction with p-chlorobenzyl mercaptan (V) affords sulconazole.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(I) |
31092 |
2,2',4'-trichloroacetophenone; 2-chloro-1-(2,4-dichlorophenyl)-1-ethanone
|
4252-78-2 |
C8H5Cl3O |
详情 | 详情
|
(II) |
32200 |
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-1-ethanone
|
46503-52-0 |
C11H8Cl2N2O |
详情 | 详情
|
(III) |
14550 |
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-1-ethanol; alpha-(2,4-Dichlorophenyl)-1H-imidazole-1-ethanol; 1-(2',4'-Dichlorophenyl)-2-(1-imidazolyl)ethanol
|
24155-42-8 |
C11H10Cl2N2O |
详情 | 详情
|
(IV) |
32673 |
1-[2-chloro-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
|
|
C11H9Cl3N2 |
详情 |
详情
|
(V) |
32674 |
(4-chlorophenyl)methanethiol; 4-chlorobenzylhydrosulfide
|
6258-66-8 |
C7H7ClS |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(IX) The esterification of 2,4-dichloromandelic acid (I) with methanol and sulfuric acid gives the corresponding methyl ester (II), which by treatment with NH3 in methanol yields 2,4-dichloromandelamide (III). The alkylation of (III) with allyl chloride (IV) and NaH in THF affords 2-allyloxy-2-(2,4-dichlorophenyl)acetamide (V), which is hydrolyzed with refluxing aqueous HCl giving 2-allyloxy-2-(2,4-dichlorophenyl)acetic acid (VI). The reduction of (VI) with LiAlH4 in refluxing ether yields 2-allyloxy-2-(2,4-dichlorophenyl)ethanol (VII), which is esterified with methanesulfonyl chloride in pyridine to afford 2-allyloxy-2-(2,4-dichlorophenyl) ethanol methanesulfonate (VIII). Finally, this compound is condensed with 1H-imidazole (IX) in refluxing DMF.
【1】
GB 1522848 .
|
【2】
Serradell, M.N.; Blancafort, P.; Castaner, J.; de Angelis, L.; Imazalil. Drugs Fut 1982, 7, 4, 254.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36400 |
2-(2,4-dichlorophenyl)-2-hydroxyacetic acid
|
|
C8H6Cl2O3 |
详情 |
详情
|
(II) |
36401 |
methyl 2-(2,4-dichlorophenyl)-2-hydroxyacetate
|
|
C9H8Cl2O3 |
详情 |
详情
|
(III) |
36402 |
2-(2,4-dichlorophenyl)-2-hydroxyacetamide
|
|
C8H7Cl2NO2 |
详情 |
详情
|
(IV) |
13235 |
Allyl chloride; 3-Chloro-1-propene
|
107-05-1 |
C3H5Cl |
详情 | 详情
|
(V) |
36403 |
2-(allyloxy)-2-(2,4-dichlorophenyl)acetamide
|
|
C11H11Cl2NO2 |
详情 |
详情
|
(VI) |
36404 |
2-(allyloxy)-2-(2,4-dichlorophenyl)acetic acid
|
|
C11H10Cl2O3 |
详情 |
详情
|
(VII) |
36405 |
2-(allyloxy)-2-(2,4-dichlorophenyl)-1-ethanol
|
|
C11H12Cl2O2 |
详情 |
详情
|
(VIII) |
36406 |
3-(allyloxy)-3-(2,4-dichlorophenyl)propyl methanesulfonate
|
|
C13H16Cl2O4S |
详情 |
详情
|
(IX) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(IX) The bromination of 2,4-dichloroacetophenone (X) with Br2 in refluxing methanol gives 2,4-dichlorophenacyl bromide (XI), which is condensed with 1H-imidazole (IX) in methanol to yield 2,4-dichloro-alpha-(1-imidazolyl)acetophenone (XII). The reduction of (XII) with NaBH4 in refluxing methanol affords 1-(2,4-chlorophenyl)-2-(1-imidazolyl)ethanol (XIII), which is finally alkylated with allyl chloride (IV) and NaH in refluxing DMF.
【1】
Serradell, M.N.; Blancafort, P.; Castaner, J.; de Angelis, L.; Imazalil. Drugs Fut 1982, 7, 4, 254.
|
【2】
Godefroi, E.F.; Schuermans, J.L.; US 3658813 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
13235 |
Allyl chloride; 3-Chloro-1-propene
|
107-05-1 |
C3H5Cl |
详情 | 详情
|
(IX) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(X) |
36407 |
1-(2,4-dichlorophenyl)-1-ethanone; 2',4'-dichloroaetophenone
|
2234-16-4 |
C8H6Cl2O |
详情 | 详情
|
(XI) |
36408 |
2-bromo-1-(2,4-dichlorophenyl)-1-ethanone
|
|
C8H5BrCl2O |
详情 |
详情
|
(XII) |
32200 |
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-1-ethanone
|
46503-52-0 |
C11H8Cl2N2O |
详情 | 详情
|
(XIII) |
14550 |
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-1-ethanol; alpha-(2,4-Dichlorophenyl)-1H-imidazole-1-ethanol; 1-(2',4'-Dichlorophenyl)-2-(1-imidazolyl)ethanol
|
24155-42-8 |
C11H10Cl2N2O |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(V) The cyclization of 2,4-dichlorophenacyl bromide (I) with glycerol (II) gives cis-2-(2,4-dichlorophenyl)-2-bromomethyl-4-hydroxymethyl-1,3-dioxolane (III), which is then benzoylated with benzoyl chloride (A) yielding cis-2-(2,4-dichlorophenyl)-2-bromomethyl-4-benzoyloxymethyl-1,3-dioxolane (IV). The condensation of (IV) with 1H-imidazole (V) affords cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-4-benzoyloxymethyl-1,3-dioxolane (VI), which is then debenzoylated in basic medium giving cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-4-hydroxymethyl-1,3-dioxolane (VII). The reaction of (VII) with methanesulfonyl chloride (B) yields cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-ylmethyl methanesulfonate (VIII). Finally, this compound is condensed with 1-acetyl-4-(4-hydroxyphenyl)piperazine (IX) by means of NaH in benzene - DMSO. Compound (IX) is obtained by reaction of 4-(1-piperazinyl)phenol dihydrobromide (X) with acetic anhydride by means of K2CO3 in refluxing acetic acid.
【1】
Heeres, J.; et al.; DE 2804096 .
|
【2】
Blancafort, P.; Sweetman, A.J.; Castaner, J.; Serradell, M.N.; Ketoconazole. Drugs Fut 1979, 4, 7, 496.
|
【3】
Backx, L.J.J.; Mostmans, J.H.; Heeres, J. (Janssen Pharmaceutica NV); 1-(1,3-Dioxolan-2-ylmethyl)-1H-imidazoles. US 4335125 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(B) |
13467 |
Methanesulfonyl chloride;Mesyl chloride;Methylsulfonyl chloride;Methanesulfonic acid chloride;Methanesulfonyl chloride;Methanesulphonyl chloride |
124-63-0 |
CH3ClO2S |
详情 | 详情
|
(I) |
36408 |
2-bromo-1-(2,4-dichlorophenyl)-1-ethanone
|
|
C8H5BrCl2O |
详情 |
详情
|
(II) |
13289 |
Glycerine; Glycerin; Glycerol
|
56-81-5 |
C3H8O3 |
详情 | 详情
|
(III) |
39602 |
[(2S,4R)-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methanol
|
|
C11H11BrCl2O3 |
详情 |
详情
|
(IV) |
30485 |
[(2S,4S)-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methyl benzoate; cis-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methyl benzoate
|
|
C18H15BrCl2O4 |
详情 |
详情
|
(V) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(VI) |
39603 |
[(2S,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl benzoate
|
|
C21H18Cl2N2O4 |
详情 |
详情
|
(VII) |
39604 |
[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methanol
|
170210-50-1 |
C14H14Cl2N2O3 |
详情 | 详情
|
(VIII) |
39605 |
[(2S,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl methanesulfonate; cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl methanesulfonate
|
|
C15H16Cl2N2O5S |
详情 |
详情
|
(IX) |
29119 |
1-Acetyl-4-(4-hydoxyphenyl)piperazine; 1-[4-(4-hydroxyphenyl)-1-piperazinyl]-1-ethanone; N-Acetyl-4-(4-hydoxyphenyl)piperazine
|
67914-60-7 |
C12H16N2O2 |
详情 | 详情
|
(X) |
39606 |
4-(1-piperazinyl)phenol; 1-(4-Hydroxyphenyl)piperazine
|
56621-48-8 |
C10H14N2O |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) The reaction of 4-(5-iodo-2-methylbenzoyl)-3,5-dimethylbenzoic acid (I) with imidazole (II) by means of K2CO3, KF and Cu in DMF at 135 C gives 4-[5-(1-imidazolyl)-2-methylbenzoyl]-3,5-dimethylbenzoic acid (III), which is then reduced with NaBH4 in hot aqueous NaOH.
【1】
Mineo, T. (Welfide Corporation); Imidazole derivative. JP 1986277670 .
|
【2】
Prous, J.; Castaner, J.; Y-20811. Drugs Fut 1988, 13, 11, 970.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23247 |
4-(5-iodo-2-methylbenzoyl)-3,5-dimethylbenzoic acid
|
|
C17H15IO3 |
详情 |
详情
|
(II) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(III) |
23249 |
4-[5-(1H-imidazol-1-yl)-2-methylbenzoyl]-3,5-dimethylbenzoic acid
|
|
C20H18N2O3 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(III) The reaction for preparing the esters is shown schematically by the condensation of 1-methyl-5-(4-methylbenzoyl)pyrrol-2-acetic acid and 7-(2-oxyethyl)theophylline as a general example, giving rise to the formation of the 1-methyl-5-(4-methylbenzoyl)pyrrol-2-acetate of 7-(2-oxyethyl)theophylline.
【1】
Baglioni, A. (Medosan); Ester derivs. of 7-(omega-oxyalkyl)theophylline and their pharmaceutical activity. EP 0177659; US 4618612 .
|
【2】
Anzalone, M.; Barone, D.; Pharmacological profile of MED 27, a new platelet antiaggregating agent. Pharmacol Res 1992, 26, Suppl 1, 174.
|
【3】
Tubaro, E.; MED 27. Drugs Fut 1993, 18, 7, 601.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11352 |
2-[1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid
|
|
C15H15NO3 |
详情 |
详情
|
(II) |
11353 |
1,1'-Carbonyldiimidazole; Di(1H-imidazol-1-yl)methanone; N,N-Carbonyldiimidazole; 1,1'-Carbonylbis(1H-imidazole)
|
530-62-1 |
C7H6N4O |
详情 | 详情
|
(III) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(IV) |
11355 |
1-(1H-Imidazol-1-yl)-2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]-1-ethanone
|
|
C18H17N3O2 |
详情 |
详情
|
(V) |
11356 |
7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione; 7-(2-Hydroxy-ethyl)-1,3-dimethyl-3,7-dihydro-purine-2,6-dione
|
519-37-9 |
C9H12N4O3 |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(V) The cyclization of 3,4-diaminobenzophenone (I) with acetylimidic acid ethyl ester (II) in refluxing methanol gives 5-benzoyl-2-methylbenzimidazole (III), which is reduced with NaBH4 in methanol yielding 5-(alpha-hydroxybenzyl)-2-methylbenzimidazole (IV). Finally, this compound is condensed with imidazole (V) in refluxing acetonitrile.
【1】
Raeymaekers, A.H.M.; Freyne, E.J.E.; Sanz, G.C. (Janssen Pharmaceutica NV); Novel (1H-imidazol-1-ylmethyl) substd. benzimidazole derivs. AU 8778385; EP 0260744; JP 1989085975; US 4859684 .
|
【2】
Castaner, J.; Prous, J.; Irtemazole. Drugs Fut 1991, 16, 12, 1094.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12830 |
(3,4-Diaminophenyl)phenylmethanone; 3,4-Diaminobenzophenone
|
39070-63-8 |
C13H12N2O |
详情 | 详情
|
(II) |
12831 |
ethyl ethanimidoate
|
1000-84-6 |
C4H9NO |
详情 | 详情
|
(III) |
12832 |
(2-Methyl-1H-benzimidazol-5-yl)(phenyl)methanone
|
|
C15H12N2O |
详情 |
详情
|
(IV) |
12833 |
(2-Methyl-1H-benzimidazol-5-yl)(phenyl)methanol
|
|
C15H14N2O |
详情 |
详情
|
(V) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线20
该中间体在本合成路线中的序号:
(V) A new synthesis for flutrimazole has been reported:
The Grignard condensation of 2-fluorobenzophenone (I) with 4-fluorophenylmagnesium bromide (II) gives the corresponding triphenylcarbinol (III), which by reaction with refluxing SOCl2 is converted to the trityl chloride (IV). Finally, this compound is condensed with imidazole (V) in acetonitrile.
【1】
Forn, J.; Bartrolí, J.; Algueró, M.; Boncompte, E.; Synthesis and antifungal activity of a series of difluorotritylimidazoles. Arzneim-Forsch Drug Res 1992, 42, 6, 832. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13642 |
(2-Fluorophenyl)(phenyl)methanone; 2-Fluorobenzophenone
|
342-24-5 |
C13H9FO |
详情 | 详情
|
(II) |
13643 |
4-fluorophenyl magnesium bromide;Bromo(4-fluorophenyl)magnesium;bromo(p-fluorophenyl)Magnesium;p-Fluorophenylmagnesium bromide |
352-13-6 |
C6H4BrFMg |
详情 | 详情
|
(III) |
13644 |
(2-Fluorophenyl)(4-fluorophenyl)phenylmethanol
|
|
C19H14F2O |
详情 |
详情
|
(IV) |
13645 |
1-[Chloro(4-fluorophenyl)benzyl]-2-fluorobenzene
|
|
C19H13ClF2 |
详情 |
详情
|
(V) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
(IV) The reduction of 2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one (I) with NaBH4 in methanol gives the corresponding alcohol (II), which is treated with refluxing SOCl2 to yield 2,4,5-trichloro-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (III). Finally, this compound is condensed with imidazole (IV) in refluxing DMF and salified with nitric acid in isopropanol/diisopropyl ether.
【1】
Rabasseda, X.; Castaner, J.; Font, E.; Eberconazole Nitrate. Drugs Fut 1996, 21, 8, 792.
|
【2】
Andreoli Rovati, R.; Cepero Mestres, R. (Sociedad Espanola de Especialidades Farmaco-Terapeuticas SA); Dichlorosubstd. imidazole derivs. as antifungal agents. AU 9052554; EP 0392326; US 5177099 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14362 |
2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one
|
|
C15H10Cl2O |
详情 |
详情
|
(II) |
14363 |
2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ol
|
|
C15H12Cl2O |
详情 |
详情
|
(III) |
14364 |
2,4,5-trichloro-10,11-dihydro-5H-dibenzo[a,d]cycloheptene
|
|
C15H11Cl3 |
详情 |
详情
|
(IV) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(IX) A process useful for the industrial preparation of eberconazole has been reported: The Wittig condensation of 2-(methoxycarbonyl)benzyl(triphenyl)phosphonium bromide (I) with 3,5-dichlorobenzaldehyde (II) by means of NaH in DMF gives 2-[2-(3,5-dichlorophenyl)vinyl]benzoic acid methyl ester (III), which is hydrolyzed with NaOH in methanol to the corresponding free acid (IV). The hydrogenation of (IV) with H2 over Pd/C in methanol affords 2-[2-(3,5-dichlorophenyl)ethyl]benzoic acid (V), which is cyclized to 2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one (VI) by means of polyphosphoric acid. The reduction of (VI) with NaBH4 yields the corresponding carbinol (VII), which is treated with SOCl2 affording the chloride (VIII). Finally, this compound is condensed with imidazole (IX) in refluxing DMF.
【1】
Farrerons Gallemi, C.; Monserrat Vidal, C.; Miquel Bono, I.J. (Laboratorios Salvat SA); Process for the preparation of eberconazol and intermediates thereof. WO 9921838 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26013 |
[2-(methoxycarbonyl)benzyl](triphenyl)phosphonium bromide
|
|
C27H24BrO2P |
详情 |
详情
|
(II) |
24169 |
3,5-dichlorobenzaldehyde
|
10203-08-4 |
C7H4Cl2O |
详情 | 详情
|
(III) |
26014 |
methyl 2-[(E)-2-(3,5-dichlorophenyl)ethenyl]benzoate
|
|
C16H12Cl2O2 |
详情 |
详情
|
(IV) |
26015 |
2-[(E)-2-(3,5-dichlorophenyl)ethenyl]benzoic acid
|
|
C15H10Cl2O2 |
详情 |
详情
|
(V) |
26016 |
2-(3,5-dichlorophenethyl)benzoic acid
|
|
C15H12Cl2O2 |
详情 |
详情
|
(VI) |
14362 |
2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one
|
|
C15H10Cl2O |
详情 |
详情
|
(VII) |
14363 |
2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ol
|
|
C15H12Cl2O |
详情 |
详情
|
(VIII) |
14364 |
2,4,5-trichloro-10,11-dihydro-5H-dibenzo[a,d]cycloheptene
|
|
C15H11Cl3 |
详情 |
详情
|
(IX) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(III) The reaction of 2-bromo-2'-hydroxyacetophenone (I) with sodium methylmercaptide in methanol gives 2'-hydroxy-2-(methylthio)acetophenone (II), which is condensed with imidazole (III) by means of SOCl2 in dichloromethane to afford (E)-1-[1-(2-hydroxyphenyl)-2-(methylthio)vinyl]-1H-imidazole (IV), along with some of the (Z)-isomer. Finally, (IV) is condensed with pentyl bromide (V) by means of KOH in DMF.
【1】
Ogawa, M.; Matsuda, H.; Asaoka, T.; Oono, J.; Katori, T. (SSP Co., Ltd.); Imidazole derivs. EP 0227011; JP 1988146864; US 4740601 .
|
【2】
Matsuda, H.; Iwasa, A.; Asaoka, T.; Nakashima, T.; Eto, H.; Kuraishi, T.; Ogawa, M.; Yamaguchi, K.; Synthesis and antifungal activities of a series of (1,2-disubstituted vinyl)imidazoles. Chem Pharm Bull 1991, 39, 9, 2301.
|
【3】
Fromtling, R.A.; Castaner, J.; Neticonazole Hydrochloride. Drugs Fut 1993, 18, 4, 324.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14456 |
2-bromo-1-(2-hydroxyphenyl)-1-ethanone
|
2491-36-3 |
C8H7BrO2 |
详情 | 详情
|
(II) |
14457 |
1-(2-hydroxyphenyl)-2-(methylsulfanyl)-1-ethanone
|
|
C9H10O2S |
详情 |
详情
|
(III) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(IV) |
14459 |
2-[(E)-1-(1H-imidazol-1-yl)-2-(methylsulfanyl)ethenyl]phenol
|
|
C12H12N2OS |
详情 |
详情
|
(V) |
14460 |
1-bromopentane; n-Amyl Bromide
|
110-53-2 |
C5H11Br |
详情 | 详情
|
合成路线24
该中间体在本合成路线中的序号:
(II) The condensation of 5-chloro-2-nitroaniline (I) with imidazole (II) by means of KOH in DMSO gives 5-(1-imidazolyl)-2-nitroaniline (III). Hydrogenation of (III) over Pd/C in 1N HCl gives the diamine (IV), which is condensed with oxalic acid (V) in 4N HCl yielding 6-(1-imidazolyl)quinoxaline-2,3(1H,4H)-dione hydrochloride (VI). Finally, this compound is nitrated with HNO3/H2SO4.
【1】
Ngo, J.; Rabasseda, X.; Castaner, J.; YM-900. Drugs Fut 1997, 22, 3, 256.
|
【2】
Sakamoto, S.; Ohmori, J.; Shimizu-Sasamata, M.; et al.; Imidazolylquinoxaline-2,3-diones: Novel and potent antagonists of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) excitatory amino acid receptor. 12th Int Symp Med Chem (Sept 13-17, Basel) 1992, Abst P-022.A.. |
【3】
Ohmori, J.; Sakamoto, S.; Kubota, H.; Shimizu-Sasamata, M.; Okada, M.; Kawasaki, S.; Hidaka, K.; Togami, J.; Furuya, T.; Murase, K.; 6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: Structure-activity relationships for the AMPA-type non-NMDA receptor. J Med Chem 1994, 37, 4, 467-75. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15709 |
5-chloro-2-nitrophenylamine; 5-chloro-2-nitroaniline
|
1635-61-6 |
C6H5ClN2O2 |
详情 | 详情
|
(II) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(III) |
15711 |
5-(1H-imidazol-1-yl)-2-nitroaniline; 5-(1H-imidazol-1-yl)-2-nitrophenylamine
|
|
C9H8N4O2 |
详情 |
详情
|
(IV) |
15712 |
4-(1H-imidazol-1-yl)-1,2-benzenediamine; 2-amino-4-(1H-imidazol-1-yl)phenylamine
|
|
C9H10N4 |
详情 |
详情
|
(V) |
15713 |
Oxalic acid
|
144-62-7 |
C2H2O4 |
详情 | 详情
|
(VI) |
15714 |
6-(1H-imidazol-1-yl)-1,4-dihydro-2,3-quinoxalinedione hydrochloride
|
|
C11H9ClN4O2 |
详情 |
详情
|
合成路线25
该中间体在本合成路线中的序号:
(IX) Swern oxidation of protected (hydroxymethyl)pyrrolidine (I), followed by Wittig condensation of the resulting aldehyde (II) with methylene triphenylphosphorane provided vinylpyrrolidine (III). Hydroboration of (III) with 9-borabicyclo[3.3.1]nonane and subsequent oxidative treatment with sodium perborate gave alcohol (IV). Interconversion of the N-benzyl protecting group for an allyloxycarbonyl group was achieved by catalytic hydrogenation and then treatment of the deprotected amine (V) with allyloxycarbonyl chloride (VI). Alcohol (VII) was activated as the corresponding mesylate (VIII), which was condensed with imidazole (IX) in the presence of t-BuOK to afford the N-alkylated imidazole (X). Acid deprotection of the silyl ether of (X) yielded the corresponding secondary alcohol, which was further converted to mesylate (XI). Subsequent displacement in (XI) by potassium thioacetate furnished the thioacetate ester (XII).
【1】
Barrett, D.; Azami, H.; Matsuda, K.; et al.; Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems. Part III: Novel 2-alkyl substituents containing cationic heteroaromatics linked via a C-N bond. Bioorg Med Chem 1999, 7, 8, 1665. |
【2】
Murata, M.; Tsutsumi, H.; Matsuda, K.; Hattori, K.; Nakajima, T. (Fujisawa Pharmaceutical Co., Ltd.); Substd. 3-pyrrolidinylthio-carbapenems as antimicrobial agents. EP 0636133; JP 1995505650; WO 9321186 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
12893 |
Ethanethioic S-acid
|
|
C2H4OS |
详情 |
详情
|
|
38115 |
3-[(chlorocarbonyl)oxy]-1-propene
|
2937-50-0 |
C4H5ClO2 |
详情 | 详情
|
(I) |
32605 |
((2S,4S)-1-benzyl-4-[[tert-butyl(dimethyl)silyl]oxy]pyrrolidinyl)methanol
|
|
C18H31NO2Si |
详情 |
详情
|
(II) |
32606 |
(2S,4S)-1-benzyl-4-[[tert-butyl(dimethyl)silyl]oxy]-2-pyrrolidinecarbaldehyde
|
|
C18H29NO2Si |
详情 |
详情
|
(III) |
32607 |
(2S,4S)-1-benzyl-4-[[tert-butyl(dimethyl)silyl]oxy]-2-vinylpyrrolidine; (3S,5S)-1-benzyl-5-vinylpyrrolidinyl tert-butyl(dimethyl)silyl ether
|
|
C19H31NOSi |
详情 |
详情
|
(IV) |
32608 |
2-((2R,4S)-1-benzyl-4-[[tert-butyl(dimethyl)silyl]oxy]pyrrolidinyl)-1-ethanol
|
|
C19H33NO2Si |
详情 |
详情
|
(V) |
32609 |
2-((2R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]pyrrolidinyl)-1-ethanol
|
|
C12H27NO2Si |
详情 |
详情
|
(VII) |
32610 |
allyl (2R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-(2-hydroxyethyl)-1-pyrrolidinecarboxylate
|
|
C16H31NO4Si |
详情 |
详情
|
(VIII) |
32611 |
allyl (2R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-[2-[(methylsulfonyl)oxy]ethyl]-1-pyrrolidinecarboxylate
|
|
C17H33NO6SSi |
详情 |
详情
|
(IX) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(X) |
32612 |
allyl (2R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-[2-(1H-imidazol-1-yl)ethyl]-1-pyrrolidinecarboxylate
|
|
C19H33N3O3Si |
详情 |
详情
|
(XI) |
32613 |
allyl (2R,4S)-2-[2-(1H-imidazol-1-yl)ethyl]-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate
|
|
C14H21N3O5S |
详情 |
详情
|
(XII) |
31614 |
(3S)-5-chloro-3-([[(1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]amino]carbonyl)-5-hexenoic acid
|
|
C21H36ClNO5 |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(V) Reaction of the Grignard reagent derived from 4-chlorobenzyl bromide (I) with allyl bromide (II) gives 4-(4-chlorophenyl)but-1-ene (III), which is epoxidized with peracetic acid in dichloromethane to yield 4-(4-chlorophenyl)-1,2-epoxybutane (IV). Opening of (IV) with the anion of imidazole (V) gives 1-[4-(4-chlorophenyl)-2-hydroxybutyl]imidazole (VI), which is oxidized under Swern conditions to 4-(4-chlorophenyl)-1-(1-imidazolyl)-2-butanone (VII). Ketone (VII) is then reacted with (S)-solketal tosylate [(S)-1,2-O-isopropylideneglycerol-3-O-tosylate] (VIII) in the presence of p-toluenesulfonic acid in toluene to give a mixture of stereoisomers, and (2S,4S)-cis-2-[2-(4-chlorophenyl)ethyl]-2-(imidazol-1-ylmethyl)-4-(p-toluenesulfonyloxy)methyl-1,3-dioxolane (IX) is then separated by crystallization. Finally, (IX) is treated with 4-aminothiophenol (X) in the presence of potassium carbonate in acetone.
【1】
Dyson, N.H.; Gardner, J.O.; Prince, A.; Kertesz, D.J. (Syntex (USA), Inc.); Process for preparing 1,3-dioxolane derivs. JP 1995508002; US 5208331 .
|
【2】
Walker, K.A.; Burton, P.M.; Swinney, D.C. (Syntex (USA), Inc.); 1,3-Dioxolane derivs. as cholesterol lowering agents. JP 1992308588; US 5158949 .
|
【3】
Walker, K.A.M.; Rotstein, D.M.; Kertesz, D.J.; et al.; Selective inhibition of mammalian lanosterol 14alpha-demethylase: A possible strategy for cholesterol lowering. J Med Chem 1993, 36, 15, 2235-7.
|
【4】
Prous, J.; Mealy, N.; Castañer, J.; RS-21607-197. Drugs Fut 1994, 19, 2, 125.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16481 |
1-(bromomethyl)-4-chlorobenzene
|
622-95-7 |
C7H6BrCl |
详情 | 详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
16483 |
1-(3-butenyl)-4-chlorobenzene
|
|
C10H11Cl |
详情 |
详情
|
(IV) |
16484 |
2-(4-chlorophenethyl)oxirane
|
|
C10H11ClO |
详情 |
详情
|
(V) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(VI) |
16486 |
4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanol
|
|
C13H15ClN2O |
详情 |
详情
|
(VII) |
16487 |
4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanone
|
|
C13H13ClN2O |
详情 |
详情
|
(VIII) |
16488 |
(2S)-2,3-dihydroxypropyl 4-methylbenzenesulfonate
|
|
C10H14O5S |
详情 |
详情
|
(IX) |
16489 |
[(2S,4S)-2-(4-chlorophenethyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl 4-methylbenzenesulfonate
|
|
C23H25ClN2O5S |
详情 |
详情
|
(X) |
16490 |
4-aminophenylhydrosulfide; 4-aminothiophenol; 4-aminobenzenethiol
|
1193-02-8 |
C6H7NS |
详情 | 详情
|
合成路线27
该中间体在本合成路线中的序号:
(XIX) The reduction of benzoin (XIII) with NaBH4 in ethanol/water gives the diol (XIV), which by a pinacol rearrangement by means of H2SO4 in hot acetic acid yields the diphenylacetaldehyde (XXV). The cyclization of (XV) with methyl vinyl ketone (XVI) by means of KOH in ethanol affords the cyclohexenone (XVII), which is reduced first with H2 over Pd/C in THF and then with NaBH4 in ethanol/water giving the 4,4-diphenylcyclohexanol (IX). The reaction of (IX) with PCl3 in THF yields the dichlorophosphite (XVIII), which is treated with imidazole (XIX) in THF affording the bis imidophosphite (XX). The condensation of (XX) with the previously obtained penta tert-butyl acetate compound (VI) in THF/heptane gives the imidophosphite (XXI), which is oxidized with sodium periodate yielding the phosphoric acid diester (XXII). Finally, the hydrolysis of (XXII) with HCl in ether/water eliminates the tert-butyl groups affording the desired chelating ligand (XII).
【1】
Amedio, J.C. Jr.; et al.; A practical preparation of 4,4-diphenylcyclohexanol: A key intermediate in the synthesis of MS-325. Synth Commun 1998, 28, 20, 3895.
|
【2】
Dunham, S.O.; Lauffer, R.B. (Epix Medical, Inc.); Contrast-enhanced diagnostic imaging method for monitoring interventional therapies. WO 9917809 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
30317 |
3,6,9-Tris(tert-butoxycarbonylmethyl)-4(R)-(hydroxymethyl)-3,6,9-triazaundecanedioic acid di-tert-butyl ester
|
|
C35H65N3O11 |
详情 |
详情
|
(IX) |
30319 |
4,4-diphenylcyclohexanol
|
|
C18H20O |
详情 |
详情
|
(XII) |
30322 |
3,6,9-Tris(carboxymethyl)-4(R)-[4,4-diphenylcyclohexyloxy(hydroxy)phosphoryloxymethyl]-3,6,9-triazaundecanedioic acid
|
|
C33H44N3O14P |
详情 |
详情
|
(XIII) |
24135 |
2-hydroxy-1,2-diphenyl-1-ethanone; benzoin
|
579-44-2 |
C14H12O2 |
详情 | 详情
|
(XIV) |
30331 |
Hydrobenzoin; 1,2-diphenyl-1,2-ethanediol
|
655-48-1 |
C14H14O2 |
详情 | 详情
|
(XV) |
30323 |
2,2-diphenylacetaldehyde
|
947-91-1 |
C14H12O |
详情 | 详情
|
(XVI) |
30324 |
3-buten-2-one; methyl vinyl ketone
|
78-94-4 |
C4H6O |
详情 | 详情
|
(XVII) |
30325 |
4,4-diphenyl-2-cyclohexen-1-one
|
|
C18H16O |
详情 |
详情
|
(XVIII) |
30326 |
Dichlorophosphorous acid 4,4-diphenylcyclohexyl ester
|
|
C18H19Cl2OP |
详情 |
详情
|
(XIX) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(XX) |
30327 |
4,4-diphenylcyclohexyl di(1H-imidazol-1-yl)phosphinite
|
|
C24H25N4OP |
详情 |
详情
|
(XXI) |
30328 |
3,6,9-Tris(tert-butoxycarbonylmethyl)-4(R)-[4,4-diphenylcyclohexyloxy(1-imidazolyl)phosphoryloxymethyl]-3,6,9-triazaundecanedioic acid di-tert-butyl ester
|
|
C56H86N5O12P |
详情 |
详情
|
(XXII) |
30329 |
3,6,9-Tris(tert-butoxycarbonylmethyl)-4(R)-[4,4-diphenylcyclohexyloxy(hydroxy)phosphoryloxymethyl]-3,6,9-triazaundecanedioic acid di-tert-butyl ester
|
|
C53H84N3O14P |
详情 |
详情
|
合成路线28
该中间体在本合成路线中的序号:
(XI) The reaction of bromobenzene (I) with 14CO2 by means of Mg in ether gives the corresponding benzoic acid (II), which is treated with SOCl2 and DMAP to yield the benzoyl chloride (III). The homologation of (III) with diazomethane in ether affords the phenacyl chloride (IV), which is enantioselectively reduced with borane and a chiral borolidine catalyst in THF to give (R)-2-chloro-1-phenylethanol (V). The cyclization of (V) by means of NaOH in ethyl ether yields the oxirane (VI), which by reaction with ammonia is converted into the (R)-2-amino-1-phenylethanol (VII). The condensation of (VII) with 4'-chlorobiphenyl-4-carboxylic acid (VIII) by means of CDI in DMF provides the amide (IX), which is cyclized to the oxazoline (X) by means of methanesulfonic anhydride and TEA in THF. Finally, this compound is condensed with imidazole (XI) by heating at 125 C.
【1】
Moenius, T.; et al.; C-14 labelling of NVPVID400 - a specific vitamin D-3-hydroxylase inhibitor. J Label Compd Radiopharm 1999, 42, 11, 1053.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13365 |
Monobromobenzene; 1-Bromobenzene;Phenylbromide;bromobenzene |
108-86-1 |
C6H5Br |
详情 | 详情
|
(II) |
10202 |
Benzoic acid
|
65-85-0 |
C7H6O2 |
详情 | 详情
|
(III) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(IV) |
38669 |
2-chloro-1-phenyl-1-ethanone
|
532-27-4 |
C8H7ClO |
详情 | 详情
|
(V) |
38670 |
(1R)-2-chloro-1-phenyl-1-ethanol
|
1674-30-2 |
C8H9ClO |
详情 | 详情
|
(VI) |
38671 |
(2R)-2-phenyloxirane
|
|
C8H8O |
详情 |
详情
|
(VII) |
10173 |
(1R)-2-Amino-1-phenyl-1-ethanol
|
2549-14-6 |
C8H11NO |
详情 | 详情
|
(VIII) |
38672 |
4'-chloro[1,1'-biphenyl]-4-carboxylic acid
|
|
C13H9ClO2 |
详情 |
详情
|
(IX) |
38673 |
4'-chloro-N-[(2R)-2-hydroxy-2-phenylethyl][1,1'-biphenyl]-4-carboxamide
|
|
C21H18ClNO2 |
详情 |
详情
|
(X) |
38674 |
(5S)-2-(4'-chloro[1,1'-biphenyl]-4-yl)-5-phenyl-4,5-dihydro-1,3-oxazole
|
|
C21H16ClNO |
详情 |
详情
|
(XI) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线29
该中间体在本合成路线中的序号:
(VI) The reaction of (R)-2-phenyloxirane (I) with ammonia in ethanol gives 2-amino-1(R)-phenylethanol (II), which is condensed with 4'-chlorobiphenyl-4-carboxylic acid (III) by means of isobutyl chloroformate and TEA in DMF yielding the amide (IV). The cyclization of (IV) by means of methanesulfonic anhydride in pyridine affords the oxazoline (V), which is finally condensed with imidazole by heating at 120 C.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
38671 |
(2R)-2-phenyloxirane
|
|
C8H8O |
详情 |
详情
|
(II) |
10173 |
(1R)-2-Amino-1-phenyl-1-ethanol
|
2549-14-6 |
C8H11NO |
详情 | 详情
|
(III) |
38672 |
4'-chloro[1,1'-biphenyl]-4-carboxylic acid
|
|
C13H9ClO2 |
详情 |
详情
|
(IV) |
38673 |
4'-chloro-N-[(2R)-2-hydroxy-2-phenylethyl][1,1'-biphenyl]-4-carboxamide
|
|
C21H18ClNO2 |
详情 |
详情
|
(V) |
38674 |
(5S)-2-(4'-chloro[1,1'-biphenyl]-4-yl)-5-phenyl-4,5-dihydro-1,3-oxazole
|
|
C21H16ClNO |
详情 |
详情
|
(VI) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线30
该中间体在本合成路线中的序号:
(VI) The esterification of 2(S)-amino-2-phenylethanol (VII) with hot sulfuric acid gives the expected O-sulfate (VIII), which by treatment with hot aqueous NaOH yields the aziridine (IX). The condensation of (IX) with imidazole (VI) by heating at 120 C affords 2(R)-(1-imidazolyl)-2-phenylethan-1-amine (X). Finally, this compound is condensed with 4'-chlorobiphenyl-4-thiocarboxylic acid 2-pyridylthioester in DMF.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(VII) |
10973 |
(2S)-2-Amino-2-phenyl-1-ethanol; (S)-2-Hydroxy-1-phenylethylamine; (S)-(+)-2-Phenylglycinol; (S)-2-Amino-2-phenyl-1-ethanol
|
20989-17-7 |
C8H11NO |
详情 | 详情
|
(VIII) |
38675 |
(2S)-2-amino-2-phenylethyl hydrogen sulfate
|
|
C8H11NO4S |
详情 |
详情
|
(IX) |
38676 |
(2S)-2-phenylaziridine
|
|
C8H9N |
详情 |
详情
|
(X) |
38677 |
(2R)-2-(1H-imidazol-1-yl)-2-phenyl-1-ethanamine; (2R)-2-(1H-imidazol-1-yl)-2-phenylethylamine
|
|
C11H13N3 |
详情 |
详情
|
(XI) |
38678 |
S-(2-pyridinyl) 4'-chloro[1,1'-biphenyl]-4-carbothioate
|
|
C18H12ClNOS |
详情 |
详情
|
合成路线31
该中间体在本合成路线中的序号:
(VII) The title compound has been obtained by two related ways: Condensation of glycine ethyl ester (II) with 2,4-difluoronirobenzene (I) provided the N-arylglycine (III), which was further reduced to the phenylenediamine derivative (IV) by catalytic hydrogenation. Acylation of diamine (IV) with ethyl chloroglyoxylate, followed by ring closure in refluxing ethanol, yielded the quinoxalinedione (V). Subsequent electrophyllic nitration of (V) furnished the 6-nitroquinoxaline (VI). The fluoride group of (III) was then displaced with imidazole (VII) in hot DMF yielding the imidazolyl quinoxaline (VIII). Finally, basic hydrolysis of the ethyl ester function of (VIII) gave the target carboxylic acid.
【1】
Shishikura, J.; Inami, H.; Sakamoto, S.; Tsukamoto, S.; Sasamata, M.; Okada, M.; Fujii, M. (Yamanouchi Pharmaceutical Co., Ltd.); 1,2,3,4-Tetrahydroquinoxalindione deriv.. EP 0784054; US 6096743; WO 9610023 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
58528 |
ethyl 2-(5-fluoro-2-nitroanilino)acetate
|
|
C10H11FN2O4 |
详情 |
详情
|
(IV) |
58529 |
ethyl 2-(2-amino-5-fluoroanilino)acetate
|
|
C10H13FN2O2 |
详情 |
详情
|
(V) |
58530 |
ethyl 2-[7-fluoro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate
|
|
C12H11FN2O4 |
详情 |
详情
|
(VI) |
58531 |
ethyl 2-[7-fluoro-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate
|
|
C12H10FN3O6 |
详情 |
详情
|
(VII) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(VIII) |
58532 |
ethyl 2-[7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalinyl]acetate
|
|
C15H13N5O6 |
详情 |
详情
|
合成路线32
该中间体在本合成路线中的序号:
(IV) The Vilsmeier-Haack formylation of 3-beta-acetoxyandrost-5-en-17-one (I) with POCl3/DMF provides the desired chloro aldehyde (III) along with minor amounts of the vinyl chloride (II), which are separated by column chromatography. Condensation of (III) with imidazole (IV) by means of K2CO3 in hot DMF yields derivative (V), which by decarbonylation of its 16-formyl group employing a modified Wilkinson’s catalyst gives (VI). The hydrolysis of the acetate group of (VI) with KOH in methanol affords the corresponding alcohol (VII), which is finally oxidized with aluminum isopropoxide and 1-methyl-4-piperidone in refluxing xylene.
【1】
Njar, V.C.O.; Grigoryev, D.N.; Long, B.J.; Kato, K.; Brodie, A.M.H.; Nnane, I.P.; Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17alpha-hydroxylase-C17,20-lyase (P45017alpha): Potential agents for the treatment of prostate cancer. J Med Chem 1998, 41, 6, 902. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20083 |
Prasterone acetate;3b-Hydroxy-5-androstene-17-one acetate;Dehydroisoandrosterone acetate;Dehydroepiandrosterone 3-acetate;Dehydroepiandrosterone acetate;(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate |
853-23-6 |
C21H30O3 |
详情 | 详情
|
(II) |
42853 |
(3S,8R,9S,10R,13S,14S)-17-chloro-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
|
|
C21H29ClO2 |
详情 |
详情
|
(III) |
42854 |
(3S,8R,9S,10R,13S,14S)-17-chloro-16-formyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
|
|
C22H29ClO3 |
详情 |
详情
|
(IV) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(V) |
42859 |
(3S,8R,9S,10R,13S,14S)-16-formyl-17-(1H-imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
|
|
C25H32N2O3 |
详情 |
详情
|
(VI) |
42860 |
(3S,8R,9S,10R,13S,14S)-17-(1H-imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
|
|
C24H32N2O2 |
详情 |
详情
|
(VII) |
42861 |
(3S,8R,9S,10R,13S,14S)-17-(1H-imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
|
|
C22H30N2O |
详情 |
详情
|
合成路线33
该中间体在本合成路线中的序号:
(XX) Pyridone (XII) was converted to its dianion with LDA and then alkylated with propyl bromide to give the butyl pyridone (XIII). This was converted into bromopyridine (XIV) by subsequent treatment with PBr3. The nitrile group of (XIV) was then reduced to aldehyde (XV) using diisobutylaluminum hydride. The aldehye (XV) underwent a Heck reaction with tert-butyl acrylate (XVI) using tri-o-tolylphosphine and a palladium catalyst to provide unsaturated ester (XVII). Further condensation of the aldehyde group of (XVII) with (S,S)-pseudoephedrine (XVIII) produced the chiral oxazolidine (XIX). Alcohol (XI) was then protected as the silyl ether (XXI) using tert-butyldimethylsilyl chloride. After its conversion to the organolithium reagent with tert-butyllithium, addition to pyridyl acrylate (XIX) gave intermediate (XXII), and further acidic work-up removed the chiral auxiliary to afford aldehyde (XXIII).
【1】
Frey, L.F.; Devine, P.N.; Tschaen, D.M.; Dolling, U.H.; Tillyer, R.D.; Kato, Y. (Banyu Pharmaceutical Co., Ltd.; Merck & Co., Inc.); Stereoselective deoxygenation reaction. EP 0923557; JP 1999514676; WO 9806700 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
27558 |
(2S)-3-(2-bromo-5-methoxyphenyl)-2-methyl-1-propanol
|
|
C11H15BrO2 |
详情 |
详情
|
(XII) |
27560 |
6-methyl-2-oxo-1,2-dihydro-3-pyridinecarbonitrile
|
4241-27-4 |
C7H6N2O |
详情 | 详情
|
(XIII) |
27561 |
6-butyl-2-oxo-1,2-dihydro-3-pyridinecarbonitrile
|
|
C10H12N2O |
详情 |
详情
|
(XIV) |
27562 |
2-bromo-6-butylnicotinonitrile
|
|
C10H11BrN2 |
详情 |
详情
|
(XV) |
27563 |
2-bromo-6-butylnicotinaldehyde
|
|
C10H12BrNO |
详情 |
详情
|
(XVI) |
12760 |
tert-butyl acrylate
|
1663-39-4 |
C7H12O2 |
详情 | 详情
|
(XVII) |
27564 |
tert-butyl (E)-3-(6-butyl-3-formyl-2-pyridinyl)-2-propenoate
|
|
C17H23NO3 |
详情 |
详情
|
(XVIII) |
27565 |
(1S,2S)-2-amino-1-phenyl-1-propanol
|
|
C9H13NO |
详情 |
详情
|
(XIX) |
27566 |
tert-butyl (E)-3-[6-butyl-3-[(4S,5S)-3,4-dimethyl-5-phenyl-1,3-oxazolidin-2-yl]-2-pyridinyl]-2-propenoate
|
|
C27H36N2O3 |
详情 |
详情
|
(XX) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(XXI) |
27567 |
4-bromo-3-((2S)-3-[[tert-butyl(dimethyl)silyl]oxy]-2-methylpropyl)phenyl methyl ether
|
|
C17H29BrO2Si |
详情 |
详情
|
(XXII) |
27568 |
tert-butyl (3R)-3-[6-butyl-3-[(4S,5S)-3,4-dimethyl-5-phenyl-1,3-oxazolidin-2-yl]-2-pyridinyl]-3-[2-((2S)-3-[[tert-butyl(dimethyl)silyl]oxy]-2-methylpropyl)-4-methoxyphenyl]propanoate
|
|
C44H66N2O5Si |
详情 |
详情
|
(XXIII) |
27569 |
tert-butyl (3R)-3-[2-((2S)-3-[[tert-butyl(dimethyl)silyl]oxy]-2-methylpropyl)-4-methoxyphenyl]-3-(6-butyl-3-formyl-2-pyridinyl)propanoate
|
|
C34H53NO5Si |
详情 |
详情
|
合成路线34
该中间体在本合成路线中的序号:
(I) The reaction of imidazole (I) with tert-butoxycarbonyl anhydride in ethyl acetate, followed by acetylation with acetic anhydride gives the cis-ethylenediamine derivative (II), which is isomerized to its trans isomer (III) with I2 in THF. The cyclization of (III) with hydrazone (IV) by means of Na2CO3 in hot acetonitrile yields the tetrahydropyridazine (V), which s deprotected at the amino group with HCl in ethyl acetate affording the amine (VI). The condensation of (VI) with the protected thiourea (VII) by means of HgCl2 and Et3N in DMF gives the protected guanidine (VIII), which is hydrolyzed at the ester group with KOH in methanol/water providing the carboxylic acid (IX). Finally, this compound is deprotected with TFA in dichloromethane.
The intermediate, the hydrazone derivative (IV) has been obtained by condensation of 2-ethylbutyryl hydrazide (X) with 3-bromo-2-oxobutyric acid ethyl ester in ethyl ether catalyzed by acetic acid.
【1】
Graves, B.J.; Zhang, L.; Escarpe, P.A.; Mendel, D.B.; Wang, K.-Y.; Chen, X.; Kim, C.U.; Williams, M.A.; Lawton, G.; Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitors. Bioorg Med Chem Lett 1999, 9, 13, 1751. |
【2】
Zhang, L.; et al.; Synthesis and evaluation odf tetrahydropyridazine derivatives as influenza neuraminidase inhibitors. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 183.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
31874 |
tert-butyl (Z)-2-(acetamido)ethenylcarbamate
|
|
C9H16N2O3 |
详情 |
详情
|
(III) |
31881 |
tert-butyl (E)-2-(acetamido)ethenylcarbamate
|
|
C9H16N2O3 |
详情 |
详情
|
(IV) |
31875 |
ethyl 3-bromo-2-[(Z)-2-(2-ethylbutanoyl)hydrazono]propanoate
|
|
C11H19BrN2O3 |
详情 |
详情
|
(V) |
31877 |
ethyl (5S,6S)-6-(acetamido)-5-[(tert-butoxycarbonyl)amino]-1-(2-ethylbutanoyl)-1,4,5,6-tetrahydro-3-pyridazinecarboxylate
|
|
C20H34N4O6 |
详情 |
详情
|
(VI) |
31878 |
ethyl (5S,6S)-6-(acetamido)-5-amino-1-(2-ethylbutanoyl)-1,4,5,6-tetrahydro-3-pyridazinecarboxylate
|
|
C15H26N4O4 |
详情 |
详情
|
(VII) |
21843 |
tert-butyl [(tert-butoxycarbonyl)amino]carbothioylcarbamate
|
145013-05-4 |
C11H20N2O4S |
详情 | 详情
|
(VIII) |
31879 |
ethyl (5S,6S)-6-(acetamido)-5-([[(tert-butoxycarbonyl)amino][(tert-butoxycarbonyl)imino]methyl]amino)-1-(2-ethylbutanoyl)-1,4,5,6-tetrahydro-3-pyridazinecarboxylate
|
|
C26H44N6O8 |
详情 |
详情
|
(IX) |
31880 |
(5S,6S)-6-(acetamido)-5-([[(tert-butoxycarbonyl)amino][(tert-butoxycarbonyl)imino]methyl]amino)-1-(2-ethylbutanoyl)-1,4,5,6-tetrahydro-3-pyridazinecarboxylic acid
|
|
C24H40N6O8 |
详情 |
详情
|
(X) |
31876 |
2-ethylbutanohydrazide
|
|
C6H14N2O |
详情 |
详情
|
(XI) |
25183 |
ethyl 3-bromo-2-oxopropanoate;ethyl 3-bromopyruvate;Bromopyruvic acid ethyl ester;ethyl 3-bromopyruvate;ethyl bromopyruvate |
70-23-5 |
C5H7BrO3 |
详情 | 详情
|
合成路线35
该中间体在本合成路线中的序号:
(X) Condensation of alpha-chloro-(3,4-dimethoxyphenyl)acetonitrile (I) with p-thiocresol (II) in the presence of K2CO3 gave thioether (III). Alternatively, thioether (III) was obtained by reaction of the anion of (3,4-dimethoxyphenyl)acetonitrile (IV) with p-tolyl disulfide (V). Subsequent alkylation of (III) with 1-bromo-5-chloropentane using NaH in DMSO produced the 5-chloropentyl derivative (VI). This was then condensed with tetrahydroisoquinoline (VII) to yield the tertiary amine (VIII). Alkylation of the phenolic hydroxyl group of (VIII) with 2-chloroethyl tosylate produced the 2-chloroethyl ether (IX). Finally, reactionof (IX) with imidazole (X) and NaH in DMF furnished the title compound.
【1】
Berger, D.; et al.; Novel multidrug resistance reversal agents. J Med Chem 1999, 42, 12, 2145.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25855 |
2-chloro-2-(3,4-dimethoxyphenyl)acetonitrile
|
7537-07-7 |
C10H10ClNO2 |
详情 | 详情
|
(III) |
25856 |
2-(3,4-dimethoxyphenyl)-2-[(4-methylphenyl)sulfanyl]acetonitrile
|
|
C17H17NO2S |
详情 |
详情
|
(IV) |
25857 |
2-(3,4-dimethoxyphenyl)acetonitrile
|
93-17-4 |
C10H11NO2 |
详情 | 详情
|
(VI) |
25858 |
7-chloro-2-(3,4-dimethoxyphenyl)-2-[(4-methylphenyl)sulfanyl]heptanenitrile
|
|
C22H26ClNO2S |
详情 |
详情
|
(VII) |
25860 |
7-methoxy-1,2,3,4-tetrahydro-6-isoquinolinol
|
|
C10H13NO2 |
详情 |
详情
|
(VIII) |
25861 |
2-(3,4-dimethoxyphenyl)-7-[6-hydroxy-7-methoxy-3,4-dihydro-2(1H)-isoquinolinyl]-2-[(4-methylphenyl)sulfanyl]heptanenitrile
|
|
C32H38N2O4S |
详情 |
详情
|
(IX) |
25862 |
7-[6-(2-chloroethoxy)-7-methoxy-3,4-dihydro-2(1H)-isoquinolinyl]-2-(3,4-dimethoxyphenyl)-2-[(4-methylphenyl)sulfanyl]heptanenitrile
|
|
C34H41ClN2O4S |
详情 |
详情
|
(X) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线36
该中间体在本合成路线中的序号:
By condensation of 5-sulfamoyl-2-methoxybenzoic acid (I) with 1-propyl-2-aminomethylpyrrolidine (II) by means of phosgene and imidazole in dry benzene.
【1】
Castañer, J.; Blancafort, P.; Serradell, M.N.; Prosulpride. Drugs Fut 1981, 6, 10, 630.
|
【2】
US 3342826 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(I) |
21355 |
5-(aminosulfonyl)-2-methoxybenzoic acid; 2-methoxy-5-sulfamoylbenzoic acid
|
22117-85-7 |
C8H9NO5S |
详情 | 详情
|
(II) |
39019 |
(1-propyl-2-pyrrolidinyl)methylamine; (1-propyl-2-pyrrolidinyl)methanamine
|
|
C8H18N2 |
详情 |
详情
|
合成路线37
该中间体在本合成路线中的序号:
(V) Regioselective addition of dimethylsulfoxonium methylide to 5-alpha-pregnane-3,20-dione (I) gave the epoxide (II). Opening of the epoxide ring of (II) with sodium methoxide produced the hydroxy ether (III). Bromination of (III) with Br2 in the presence of a catalytic amount of HBr afforded bromo ketone (IV). This was then condensed with imidazole (V) in refluxing acetonitrile to furnish the title compound.
【1】
Hogenkamp, D.J.; et al.; Synthesis and in vitro activity of 3beta-substituted-3alpha-hydroxypregnan-20-ones: Allosteric modulators of the GABAA receptor. J Med Chem 1997, 40, 1, 61.
|
【2】
Hogenkamp, D.L. (CoCensys, Inc.); 3alpha-Hydroxy-3beta methoxymethyl-21-heterocycle substd. steroids with anesthetic activity. WO 0066614 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46737 |
(5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one
|
566-65-4 |
C21H32O2 |
详情 | 详情
|
(II) |
46738 |
|
|
C22H34O2 |
详情 |
详情
|
(III) |
46739 |
1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3-(methoxymethyl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-ethanone
|
|
C23H38O3 |
详情 |
详情
|
(IV) |
46740 |
2-bromo-1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3-(methoxymethyl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-ethanone
|
|
C23H37BrO3 |
详情 |
详情
|
(V) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线38
该中间体在本合成路线中的序号:
(I) Alkylation of imidazole (I) with 1,7-dibromoheptane (II) by means of potassium (metal) in refluxing THF furnishes N,N'-bis-(1-imidazolyl)heptane (III), which is treated with trichloroacetyl chloride (IV) in CH2Cl2 to provide derivative (V). Nitration of (V) by means of nitric acid/sulfuric acid in Ac2O/CH2Cl2 yields compound (VI), which is then converted into intermediate (VIII) by coupling in DMF/THF with substituted pyrrole (VII). In turn, (VII) can be obtained as follows: Treatment of N-methylpyrrole (IX) with trichloroacetyl chloride (IV) in CH2Cl2 affords derivative (X), which is nitrated to yield compound (XI) in the same conditions as for nitration of (V). The last step involves coupling of (XI) with 3-(dimethylamino)propylamine (XII), followed by reduction of the nitro moiety by hydrogenation over Pd/C in DMF/MeOH. Finally, the target product can be obtained by first hydrogenation of intermediate (VIII) over Pd/C in DMF/MeOH, followed by reaction with DCC and HOBt in DMF to allow coupling with carboxylic acid (XIV), which can be obtained by saponification of ethyl ester (XIII) in EtOH.
【1】
Sharma, S.K.; et al.; Design and synthesis of novel thiazole-containing cross-linked polyamides related to tha antiviral antibiotic distamycin. J Org Chem 2000, 65, 4, 1102.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
47013 |
1,7-dibromoheptane
|
4549-31-9 |
C7H14Br2 |
详情 | 详情
|
(III) |
47014 |
1-[7-(1H-imidazol-1-yl)heptyl]-1H-imidazole
|
|
C13H20N4 |
详情 |
详情
|
(IV) |
47015 |
2,2,2-trichloroacetyl chloride
|
76-02-8 |
C2Cl4O |
详情 | 详情
|
(V) |
47016 |
2,2,2-trichloro-1-(1-[7-[2-(2,2,2-trichloroacetyl)-1H-imidazol-1-yl]heptyl]-1H-imidazol-2-yl)-1-ethanone
|
|
C17H18Cl6N4O2 |
详情 |
详情
|
(VI) |
47017 |
2,2,2-trichloro-1-(4-nitro-1-[7-[4-nitro-2-(2,2,2-trichloroacetyl)-1H-imidazol-1-yl]heptyl]-1H-imidazol-2-yl)-1-ethanone
|
|
C17H16Cl6N6O6 |
详情 |
详情
|
(VII) |
47018 |
4-amino-N-[3-(dimethylamino)propyl]-1-methyl-1H-pyrrole-2-carboxamide
|
|
C11H20N4O |
详情 |
详情
|
(VIII) |
47019 |
N-[5-([[3-(dimethylamino)propyl]amino]carbonyl)-1-methyl-1H-pyrrol-3-yl]-1-[7-[2-([[5-([[3-(dimethylamino)propyl]amino]carbonyl)-1-methyl-1H-pyrrol-3-yl]amino]carbonyl)-4-nitro-1H-imidazol-1-yl]heptyl]-4-nitro-1H-imidazole-2-carboxamide
|
|
C37H54N14O8 |
详情 |
详情
|
(IX) |
11285 |
1-Methyl-1H-pyrrole; Methylpyrrole
|
96-54-8 |
C5H7N |
详情 | 详情
|
(X) |
47020 |
2,2,2-trichloro-1-(1-methyl-1H-pyrrol-2-yl)-1-ethanone
|
|
C7H6Cl3NO |
详情 |
详情
|
(XI) |
47021 |
2,2,2-trichloro-1-(1-methyl-4-nitro-1H-pyrrol-2-yl)-1-ethanone
|
|
C7H5Cl3N2O3 |
详情 |
详情
|
(XII) |
25248 |
N-(3-aminopropyl)-N,N-dimethylamine; N(1),N(1)-dimethyl-1,3-propanediamine
|
109-55-7 |
C5H14N2 |
详情 | 详情
|
(XIII) |
47022 |
ethyl 2-amino-4-methylthiazole-5-carboxylate; ethyl 2-amino-4-methyl-1,3-thiazole-5-carboxylate
|
7210-76-6 |
C7H10N2O2S |
详情 | 详情
|
(XIV) |
47023 |
2-amino-4-methyl-1,3-thiazole-5-carboxylic acid
|
|
C5H6N2O2S |
详情 |
详情
|
合成路线39
该中间体在本合成路线中的序号:
(XIV) The dihydroxypyrimidine (IX) was converted to the 2-chloro derivative (XI) by chlorination with phosphoryl chloride and N,N-dimethylaniline, followed by treatment of the resultant dichloropyrimidine (X) with NaOAc/HOAc in aqueous EtOH. Nucleophilic displacement in chloropyrimidine (XI) with (S)-3-methylmorpholine (VIII) furnished adduct (XII). Subsequent chlorination of (XII) in hot POCl3 gave rise to the chloropyrimidine (XIII). This was then displaced with imidazole (XIV) to produce the target imidazolyl pyrimidine, which was isolated as the benzenesulfonate salt.
【1】
Powers, J.P. (Tularik Inc.); Arylsulfonic acid salts of pyrimidine-based antiviral agents. US 6410726; WO 0151485 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
55061 |
(3S)-3-methylmorpholine
|
|
C5H11NO |
详情 |
详情
|
(IX) |
55062 |
6-Methyl-5-nitropyrimidine-2,4-diol; 6-Methyl-5-nitrouracil
|
|
C5H5N3O4 |
详情 |
详情
|
(X) |
55063 |
2,4-dichloro-6-methyl-5-nitropyrimidine
|
|
C5H3Cl2N3O2 |
详情 |
详情
|
(XI) |
55064 |
2-chloro-6-methyl-5-nitro-4-pyrimidinol
|
|
C5H4ClN3O3 |
详情 |
详情
|
(XII) |
55065 |
6-methyl-2-[(3S)-3-methylmorpholinyl]-5-nitro-4-pyrimidinol
|
|
C10H14N4O4 |
详情 |
详情
|
(XIII) |
55066 |
(3S)-4-(4-chloro-6-methyl-5-nitro-2-pyrimidinyl)-3-methylmorpholine
|
|
C10H13ClN4O3 |
详情 |
详情
|
(XIV) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线40
该中间体在本合成路线中的序号:
(I) The reaction of imidazole (I) with phosgene (II) in hot benzene gives carbonyldiimidazole (III), which is condensed with 5-sulfamoyl-2-methoxybenzoic acid (IV) in THF yielding 1-(5-sulfamoyl-2-methoxybenzoyl)imidazole (V). Finally this compound is condensed with 1-methyl-2-aminomethylpyrrolidine (VI) in THF at room temperature
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(III) |
11353 |
1,1'-Carbonyldiimidazole; Di(1H-imidazol-1-yl)methanone; N,N-Carbonyldiimidazole; 1,1'-Carbonylbis(1H-imidazole)
|
530-62-1 |
C7H6N4O |
详情 | 详情
|
(IV) |
21355 |
5-(aminosulfonyl)-2-methoxybenzoic acid; 2-methoxy-5-sulfamoylbenzoic acid
|
22117-85-7 |
C8H9NO5S |
详情 | 详情
|
(V) |
60761 |
3-(1H-imidazol-1-ylcarbonyl)-4-methoxybenzenesulfonamide
|
|
C11H11N3O4S |
详情 |
详情
|
(VI) |
60759 |
(1-methyl-2-pyrrolidinyl)methylamine; (1-methyl-2-pyrrolidinyl)methanamine
|
|
C6H14N2 |
详情 |
详情
|
合成路线41
该中间体在本合成路线中的序号:
(II) Reaction of p-chlorophenacyl bromide (I) with imidazole (II) affords 4'-chloro-2-(1-imidazolyl)acetophenone (III). Sodium borohydride reduction gives the corresponding alcohol (IV) which is then alkylated with 2,6-dichlorobenzyl chloride (V) to give orconazole (VI). Treatment of (VI) with nitric acid yield the title compound
【1】
Godefroi, E.F.; et al.; The preparation and properties of derivatives of 1-phenethyl imidazole. J Med Chem 1969, 12, 5, 784.
|
【2】
Godefroi, E.F.; Heeres, J. (Janssen Pharmaceutica NV); BE 737575; DE 1940388; FR 2015913; GB 1244530; JP 76115; US 3717655; US 3839574; ZA 6905965 .
|
【3】
Arya, V.P.; Orconazole nitrate. Drugs Fut 1979, 4, 6, 432.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16720 |
2-bromo-1-(4-chlorophenyl)-1-ethanone; 2-Bromo-4'-chloroacetophenone
|
536-38-9 |
C8H6BrClO |
详情 | 详情
|
(II) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(III) |
60948 |
1-(4-chlorophenyl)-2-(1H-imidazol-1-yl)-1-ethanone
|
|
C11H9ClN2O |
详情 |
详情
|
(IV) |
60949 |
1-(4-chlorophenyl)-2-(1H-imidazol-1-yl)-1-ethanol
|
|
C11H11ClN2O |
详情 |
详情
|
(V) |
60951 |
1,3-dichloro-2-(chloromethyl)benzene
|
|
C7H5Cl3 |
详情 |
详情
|
(VI) |
60950 |
1-(4-chlorophenyl)-2-(1H-imidazol-1-yl)ethyl 2,6-dichlorobenzyl ether; 1-{2-(4-chlorophenyl)-2-[(2,6-dichlorobenzyl)oxy]ethyl}-1H-imidazole
|
|
C18H15Cl3N2O |
详情 |
详情
|
合成路线42
该中间体在本合成路线中的序号:
(III) Dexanabinol (I) was brominated using carbon tetrabromide in the presence of triphenylphosphine. The resultant allylic bromide (II) was then condensed with the lithium salt of imidazole (III) to produce the title compound.
【1】
Fink, G.; Garzon, A. (Pharmos Corp.); Novel non-psychotropic cannabinoids. WO 0198289 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59611 |
(6aS,10aS)-3-(1,1-dimethylheptyl)-9-(hydroxymethyl)-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
|
|
C25H38O3 |
详情 |
详情
|
(II) |
59612 |
(6aS,10aS)-9-(bromomethyl)-3-(1,1-dimethylheptyl)-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
|
|
C25H37BrO2 |
详情 |
详情
|
(III) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线43
该中间体在本合成路线中的序号:
(VI) Alkylation of 5,6-diphenyl-2-pyrazinol (I) with mesylate derivative (II) furnishes the pyrazinyl ether (III). The aldehyde function of (III) is then reduced to alcohol (IV) employing NaBH4 in EtOH. Chlorination of alcohol (IV) by means of SOCl2 in the presence of catalytic DMF leads to the benzyl chloride (V). This is finally condensed with imidazole (VI) in hot DMF to yield the title compound
【1】
Konno, F.; Honda, H.; Ishii, F.; et al.; Novel anti-inflammatory agents with NO (nitric oxide) inhibition. 21st Symp Med Chem (Nov 28 2001, Kyoto) 2001, Abst 2P-24.
|
【2】
Takeda, S.; Sato, S.; Takahashi, Y.; Nagao, Y.; Konno, F.; Ohtsuka, M.; Isomae, K.; Honda, H.; Hirota, H.; Kawamoto, N.; Ishii, F. (SSP Co., Ltd.); Imidazole derivs. or salts thereof and drugs containing the derivs. or the salts. EP 1295880; WO 0200648 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
62497 |
5,6-diphenyl-2-pyrazinol
|
|
C16H12N2O |
详情 |
详情
|
(II) |
62498 |
2-(4-formylphenoxy)ethyl methanesulfonate
|
|
C10H12O5S |
详情 |
详情
|
(III) |
62499 |
4-{2-[(5,6-diphenyl-2-pyrazinyl)oxy]ethoxy}benzaldehyde
|
|
C25H20N2O3 |
详情 |
详情
|
(IV) |
62500 |
(4-{2-[(5,6-diphenyl-2-pyrazinyl)oxy]ethoxy}phenyl)methanol
|
|
C25H22N2O3 |
详情 |
详情
|
(V) |
62501 |
5-{2-[4-(chloromethyl)phenoxy]ethoxy}-2,3-diphenylpyrazine; 2-[4-(chloromethyl)phenoxy]ethyl 5,6-diphenyl-2-pyrazinyl ether
|
|
C25H21ClN2O2 |
详情 |
详情
|
(VI) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线44
该中间体在本合成路线中的序号:
(II) This compound has been obtained by two similar ways:
The condensation of 6-iodo-1-methyl-1H-indole (I) with imidazole (II) by means of copper trifluoromethanesulfonate, 1,10-phenanthroline, Cs2CO3 and dibenzylideneacetone gives 6-(1-imidazolyl)-1-methyl-1H-indole (III), which is condensed with oxalyl chloride (IV) in dichloromethane to yield the adduct (V). Finally, this compound is cyclized with 2-(1-methyl-1H-indol-3-yl)acetimidic acid isopropyl ester (VI) by means of TEA in dichloromethane to afford the target pyrrolinedione.
Alternatively, indole (I) and imidazole (II) are condensed by means of Pd2(dba)3, BINAP and tBu-ONa to give 6-(1-imidazolyl)-1-methyl-1H-indole (III), which is condensed with methoxalyl chloride (VII) in dichloromethane to yield the adduct (VIII). The reduction of (VIII) with NaH2PO2 affords the methyl acetate derivative (IX), which is treated with NH4OH to provide the acetamide derivative (X). Finally, this compound is cyclized with the methoxalyl derivative (XI) (obtained by condensation of 1-methyl-1H-indole (XII) with methoxalyl chloride (VII)) by means of tBu-ONa in THF to afford the target pyrrolinedione.
【1】
Kong, N.; Lovey, A.; Specian, A.; et al.; Design and synthesis of novel orally bioavailable, water soluble bisindolylmaleimides as cell cycle inhibitors. Proc Am Assoc Cancer Res 2002, 43.
|
【2】
Lovey, A.J.; Fotouhi, N.; Kong, N. (F. Hoffmann-La Roche AG); Substd. pyrroles. WO 0146178 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
55752 |
6-iodo-1-methyl-1H-indole
|
|
C9H8IN |
详情 |
详情
|
(II) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(III) |
55753 |
6-(1H-imidazol-1-yl)-1-methyl-1H-indole
|
|
C12H11N3 |
详情 |
详情
|
(IV) |
29841 |
Oxalyl chloride; 2-Chloro-2-oxoacetyl chloride
|
79-37-8 |
C2Cl2O2 |
详情 | 详情
|
(V) |
55754 |
2-[6-(1H-imidazol-1-yl)-1-methyl-1H-indol-3-yl]-2-oxoacetyl chloride
|
|
C14H10ClN3O2 |
详情 |
详情
|
(VI) |
55755 |
isopropyl 2-(1-methyl-1H-indol-3-yl)ethanimidoate
|
|
C14H18N2O |
详情 |
详情
|
(VII) |
26971 |
2-methoxy-2-oxoacetyl chloride
|
5781-53-3 |
C3H3ClO3 |
详情 | 详情
|
(VIII) |
55756 |
methyl 2-[6-(1H-imidazol-1-yl)-1-methyl-1H-indol-3-yl]-2-oxoacetate
|
|
C15H13N3O3 |
详情 |
详情
|
(IX) |
55757 |
methyl 2-[6-(1H-imidazol-1-yl)-1-methyl-1H-indol-3-yl]acetate
|
|
C15H15N3O2 |
详情 |
详情
|
(X) |
55758 |
2-[6-(1H-imidazol-1-yl)-1-methyl-1H-indol-3-yl]acetamide
|
|
C14H14N4O |
详情 |
详情
|
(XI) |
55759 |
methyl 2-(1-methyl-1H-indol-3-yl)-2-oxoacetate
|
|
C12H11NO3 |
详情 |
详情
|
(XII) |
14119 |
1-Methylindole; 1-Methyl-1H-indole
|
603-76-9 |
C9H9N |
详情 | 详情
|
合成路线45
该中间体在本合成路线中的序号:
(III)
【1】
Janeba Z,Lin XY, Robinsw.et aL 2004.FUnctionalization of guanosine and 2'-deoxyguanosine at C6:a modified appel process and SNAr displacement of imidazole. Nucl Acid, 23(1&2): 137~147 |
【2】
Nair V, Lyons AG. 1990. Hypoxanthine nucleoside counterparts of the antibiotic, cordycepin.Tetrahedron. 46 (23): 7677一7692 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
66539 |
2-amino-9-((3aS,6S,6aS)-6-(hydroxymethyl)-2,2,3a,6a-tetramethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-3H-purin-6(9H)-one |
|
C15H21N5O5 |
详情 | 详情
|
(II) |
66540 |
9-((3aS,6S,6aS)-6-(((tert-butyldimethylsilyl)oxy)methyl)-2,2,3a,6a-tetramethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2-(tritylamino)-3H-purin-6(9H)-one |
|
C40H49N5O5Si |
详情 | 详情
|
(III) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(IV) |
66541 |
(2S,3R)-5-(2-amino-6-(1H-imidazol-1-yl)-9H-purin-9-yl)-4-(hydroxymethyl)tetrahydrofuran-2,3-diol |
|
C13H15N7O4 |
详情 | 详情
|
合成路线46
该中间体在本合成路线中的序号:
(I)
【1】
Cai W, Zhang YB, Cao YF, et al. 2005. Preparation of zoledronic acid from imidazole. 发明专利申请公开说明书.CN 1693308 |
【2】
Yadav RP, Shrukh ZG, Mukarrarn SM, et aL. 2007. Processes for the preparation of pure zoledronic acid. W0 2007069049 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
66982 |
2-(1H-Imidazol-1-yl)acetic acid |
22884-10-2 |
C5H6N2O2 |
详情 | 详情
|
合成路线47
该中间体在本合成路线中的序号:
(I)
【1】
Widler L, Jaeggi KA, Glatt M, Mueller K, et aL. 2002. Highly potent geminal bisphoaphonates, from pamidronate disodium (Aredia) to zoledmnic acid (Zameta). J Med Chem, 45 (17): 3721~3738 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
66983 |
ethyl 2-(1H-imidazol-1-yl)acetate |
|
C7H10N2O2 |
详情 | 详情
|
(III) |
66982 |
2-(1H-Imidazol-1-yl)acetic acid |
22884-10-2 |
C5H6N2O2 |
详情 | 详情
|
合成路线48
该中间体在本合成路线中的序号:
(I)
【1】
Wan R, Wang HB. 2003.Synthesis of zoledroruc acid. 中国医药工业杂志,34 (11): 513~544 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
66983 |
ethyl 2-(1H-imidazol-1-yl)acetate |
|
C7H10N2O2 |
详情 | 详情
|
(III) |
33401 |
2-(1H-imidazol-1-yl)acetic acid hydrochloride |
|
C5H6N2O2.HCl |
详情 |
详情
|
合成路线49
该中间体在本合成路线中的序号:
(I)
【1】
Kieczykowski GR, Jobson RB, Melillo DG, et aL. 1995. Preparation of (4-amino-l-hydroxybuqdidene) bisphosphonic acicl sodium salt, MK-217 (alendmnate sodium): an improved procedure for the preparation
of l-hydroxy-l,l-bisphosphonic acids. J Org Chem, 60 (25): 8310~8312 |
【2】
Patel VM, Chitturi TR, Thennati R 2005. A process for the preparation of 2-(imidazol-l-yl)-l-hydroxyethane-l,l-diphosphoruc acid. W0 2005066188 |
【3】
Zhu J.Zhou YJ, Lu JG, et al. 2003. Synthesis of zoledroruc acid. 中国新药杂志.12 (1):39~40 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(III) |
66984 |
benzyl 2-(1H-imidazol-1-yl)acetate |
|
C12H12N2O2 |
详情 | 详情
|
(IV) |
66982 |
2-(1H-Imidazol-1-yl)acetic acid |
22884-10-2 |
C5H6N2O2 |
详情 | 详情
|
合成路线50
该中间体在本合成路线中的序号:
(I)
【1】
da Silva RA, Estevam IHS, Bieber LW. 2007. Reductive methylation of primary and secondary amines and amino acids by aqueous formaldehyde and zine. Tetrahedron Lett. 48(43): 7680~7682 |
【2】
Patel CH, Dhannani S, Owen CP, et al. 2006. Synthesis, biochemical evaluation and rationalization of theinhibitory activity of a range of 4-substituted phenyl alkyl imidazolebases inhibitors of the enzyme complex 17-hydroxylase/17,20-lyase(P45017). Bioorganic & Medicinal Chemistry Letters, 16(18): 4752~4756 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
66985 |
1H-Imidazole,1-(2-phenylethyl)-;1-Phenethylimidazole |
49823-14-5 |
C11H12N2 |
详情 | 详情
|
(III) |
66986 |
ethyl 4-(1-phenethyl-1H-imidazole-5-carbonyl)piperidine-1-carboxylate |
|
C20H25N3O3 |
详情 | 详情
|
(IV) |
66987 |
(1-phenethyl-1H-imidazol-5-yl)(piperidin-4-yl)methanone |
|
C17H21N3O |
详情 | 详情
|
(V) |
66988 |
(1-methylpiperidin-4-yl)(1-phenethyl-1H-imidazol-5-yl)methanone |
|
C18H23N3O |
详情 | 详情
|
(VI) |
66989 |
11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,5-a]azepine |
|
C17H19N3 |
详情 | 详情
|
(VII) |
66990 |
(11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,5-a]azepin-3-yl)methanol |
|
C19H23N3O |
详情 | 详情
|
合成路线51
该中间体在本合成路线中的序号:
(I) The nitration of imidazole (I) with HNO3 and H2SO4 at 100 °C gives 4-nitroimidazole (II) , which by a second nitration with HNO3 and Ac2O, and optionally AcOH, affords 1,4-dinitroimidazole (III) . Rearrangement of dinitroimidazole intermediate (III) in refluxing xylene or chlorobenzene generates 2,4-dinitroimidazole (IV), which then undergoes selective nitro group displacement with HCl in refluxing chlorobenzene/water to yield 2-chloro-4-nitroimidazole (V) . Condensation of imidazole (V) with epoxide (VI) by means of Et3N in hot ethyl acetate gives the adduct (VII), which is hydrolyzed using K2CO3 in MeOH providing the vicinal diol (VIII). Selective monomesylation of diol (VIII) by means of MsCl in the presence of pyridine affords the primary mesylate (IX), which is then treated with DBU in ethyl acetate to give epoxide (X). Finally, this compound is cyclized with the 4-substitutedphenol (XI) by means of NaH in DMF .
【1】
Wuellner, G., Herkenrath, F.-W., Juelich, A., Yamada, Y., Kawabe, S.(Dynamit Nobel GmbH Explosivstoff- and Systemtechnik; Asahi Kasei Chemicals Corp.; Otsuka Pharmaceutical Co., Ltd.). Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof. CN 102131787, EP 2323990, JP 2012500183, WO 2010021409. |
【2】
Wüllner, G., Herkenrath, F.-W., Jülich, A. (Dynamit Nobel GmbH Explosivstoff-and Systemtechnik). Method for the production of 2-halogeno-4-nitroimidazole. WO 2010143007. |
【3】
Tsubouchi, H., Sasaki, H., Haraguchi, Y. et al. Synthesis and antituberculous activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles. 45th Intersci Conf Antimicrob Agents Chemother (ICAAC) (Dec 16-19, Washington, D.C.) 2005, Abst F-1473. |
【4】
Tsubouchi, H., Itoya, M., Hasegawa, T. et al. (Otsuka Pharmaceutical Co., Ltd.). 2,3-Dihydroimidazo[2,1-b]oxazole compounds. CN 10253262, EP 1555267, JP 2004149527, US 006094767, US 7262212, WO 2004033463. |
【5】
Sasaki, H., Haraguchi, Y., Itotani, M. et al. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles. J Med Chem 2006, 49(26): 7854-60. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(II) |
35764 |
4-nitro-1H-imidazole
|
3034-38-6 |
C3H3N3O2 |
详情 | 详情
|
(III) |
57884 |
1,4-dinitro-1H-imidazole
|
19182-81-1 |
C3H2N4O4 |
详情 | 详情
|
(IV) |
56023 |
2,4-dinitro-1H-imidazole
|
5213-49-0 |
C3H2N4O4 |
详情 | 详情
|
(V) |
67892 |
2-Chloro-4-nitroimidazole;2-Chloro-4-nitro-1H-imidazole |
57531-37-0 |
C3H2ClN3O2 |
详情 | 详情
|
(VI) |
67893 |
(S)-(2-methyloxiran-2-yl)methyl 4-nitrobenzoate |
118200-96-7 |
C11H11NO5 |
详情 | 详情
|
(VII) |
67895 |
(S)-3-(2-chloro-4-nitro-1H-imidazol-1-yl)-2-hydroxy-2-methylpropyl 4-nitrobenzoate |
|
C14H13ClN4O7 |
详情 | 详情
|
(VIII) |
67897 |
(S)-3-(2-chloro-4-nitro-1H-imidazol-1-yl)-2-methylpropane-1,2-diol |
|
C7H10ClN3O4 |
详情 | 详情
|
(IX) |
67896 |
(S)-3-(2-chloro-4-nitro-1H-imidazol-1-yl)-2-hydroxy-2-methylpropyl methanesulfonate |
|
C8H12ClN3O6S |
详情 | 详情
|
(X) |
67898 |
(S)-2-chloro-1-((2-methyloxiran-2-yl)methyl)-4-nitro-1H-imidazole |
|
C7H8ClN3O3 |
详情 | 详情
|
(XI) |
67894 |
4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl)phenol |
|
C18H18F3NO3 |
详情 | 详情
|